Sponsor
Daily news for curious minds.
Be the smartest person in the room. 1440 navigates 100+ sources to deliver a comprehensive, unbiased news roundup — politics, business, culture, and more — in a quick, 5-minute read. Completely free, completely factual.
Longevity Latest
The Evidence-Based Edge on Living Longer and Better
Issue 08 · 22 April 2026
WELCOME
👋 The sleep aisle problem
Here’s the thesis: the dose is the story.
The US sleep-supplement market cleared $4 billion last year. Americans sleep worse than in thirty years. The aisle is full of molecules that work — at doses the clinical literature doesn’t use, in labels the FDA can’t trust, sold to parents who think “natural” means “safe for a seven-year-old.”
Sleep is the single biggest healthspan lever we’ve got. This issue tells you which three supplements earn shelf space, which one to buy differently, and which one to stop giving to children.
The best-selling sleep gummy is mislabelled in 88% of samples — and dosed 10–30× higher than the clinical literature supports.
Inside this issue
Top 3: Magnesium L-threonate, glycine, apigenin
Spotlight: Melatonin — why 0.3mg beats 3mg
Hype Check: OLLY Sleep gummies — and the mislabelled majority
Superfood: The kiwi RCT that keeps replicating
Deep Dive: Why deep sleep vanishes with age
Biohacking Corner: The temperature-drop protocol
TOP 3
🔬 Interventions Under the Microscope
1. Magnesium L-threonate Grade B What it is. A magnesium salt bonded to threonic acid. Standard magnesium stops at the blood-brain barrier; L-threonate crosses it. Designed by an MIT lab to raise the brain magnesium that drops with age — not to modulate GABA, not to sedate. Human evidence. Two RCTs matter. Hausenblas et al. (2024), 80 adults, 1g/day for 21 days — questionnaire gains backed by actigraphy. Feng et al. (2025), 100 adults, 2g/day Magtein for six weeks — sleep quality improved, cognition didn’t. Real signal, modest samples, both industry-linked, no head-to-head against cheap glycinate. Cautions. GI upset at higher doses. Avoid with impaired kidney function or diuretics. Takeaway. The best-studied “premium” magnesium for sleep. If you’re over 50 with cognitive concerns on top of sleep ones, worth the experiment. Otherwise cheap glycinate first — not £60 a month until a head-to-head proves the premium. |
2. Glycine (3g pre-bed) Grade B What it is. An amino acid that drops core body temperature by a fraction of a degree via NMDA receptors in the suprachiasmatic nucleus — exactly what the circadian system needs to initiate sleep. Human evidence. The Bannai trials anchor it — small (n=19, n=11), Japanese, crossover, polysomnographic: 3g glycine 30 minutes before bed shortened slow-wave sleep latency without altering architecture. Next-day alertness went up, not down. A 2024 Nutrition Reviews summary landed on “real but modest” — roughly the magnitude of chamomile tea, with better mechanism data behind it. Cautions. None at this dose in healthy adults. Clozapine interaction is the one meaningful flag. Takeaway. Not dramatic. One of the few sleep supplements where polysomnography matches self-report. If you’re under 40 and stress-reactive — racing thoughts, hot sleeper, delayed onset — this is the first thing I’d reach for. Cheap, safe, reasonable. |
Personal note. I’ve cycled glycine on and off for two years. It’s the supplement I’d keep if I had to cut my stack in half. Quiet effect. No tolerance. £8 a month. |
Two B-grades in a row. Now the contender where the marketing gets ahead of the molecule.
3. Apigenin Grade C What it is. A flavonoid in chamomile, parsley, and celery. Binds the GABA-A benzodiazepine site — the Valium receptor, at roughly 1/1000th the potency. Human evidence. Marketing implies apigenin is a “natural Xanax.” Pure-apigenin human data is essentially non-existent. What we have is one 2011 pilot RCT using chamomile extract in 34 insomniacs — modest sleep-quality improvement, no statistically significant insomnia resolution. The mouse data is genuinely impressive. Commercial 50mg doses are extrapolated from animal studies, not human dose-finding. Cautions. Inhibits CYP3A4 and CYP2C9 in vitro — a genuine concern on statins, blood thinners, or HRT, where the interaction risk outweighs the thin human data. Check with your GP before adding it. Takeaway. Promising molecule promoted well ahead of its evidence. If you’re a healthy adult chasing better sleep, drink the chamomile tea before buying the 50mg capsule — the food has more evidence than the pill. |
SPOTLIGHT
⭐ Melatonin
One molecule worth defending and one worth rethinking. It’s the same one.
Melatonin is the only OTC sleep agent with a genuine chronobiological mechanism — it doesn’t sedate, it signals “it is night.” For shift workers, jet lag, DSPS, and over-55s whose pineal output has collapsed, the evidence is strong.
Here’s the inconvenient finding. Cruz-Sanabria et al. (Journal of Pineal Research 2024) pooled the trial corpus: doses from 0.3mg to 50mg produced similar sleep-onset benefits. Low doses match physiological nocturnal levels. High doses push blood levels 10–60× above anything your pineal has ever produced — for no extra sleep, and a ledger of next-day grogginess your Oura will show you by morning.
The sweet spot for a healthy adult is 0.3–0.5mg, 30–90 minutes before bed. Roughly one-sixth of an OLLY gummy.
What works. Strong evidence in jet lag, shift work, delayed sleep phase disorder, and insomnia in over-55s. Non-sedating — it signals “it is night” rather than suppressing wakefulness. Effective at physiological doses.
What doesn’t. Commercial products overshoot by 5–30×. Next-morning grogginess scales with dose. Pregnancy, autoimmunity, and SSRIs warrant clinician input.
Bottom line. ⚠️ Promising but premature as sold. The molecule works. The doses on the shelf don’t. If you’re over 55, a shift worker, or crossing time zones, this is the supplement most likely to help you — at one-sixth the dose a gummy gives you.
HYPE CHECK
🚨 OLLY Sleep Gummies
The Hype. OLLY Sleep — pharmacy darling of parenting blogs and wellness TikTok — promises to help you “fall asleep, stay asleep, wake refreshed.” £18 for 50. Three strengths: 3mg, 5mg, and 10mg (see the Spotlight above for why those numbers should make you wince). The Evidence. The labels, not the molecule, are the scandal here. Cohen et al. (JAMA 2023) tested 25 melatonin gummy brands — 88% contained amounts outside ±10% of their labelled dose, and one product carried 347% of its stated 3mg. Between 2012 and 2021, US poison control centres logged 260,435 paediatric melatonin exposures, 4,097 hospitalisations, and two deaths (Lelak et al., CDC MMWR 2022) — most involving gummies that look and taste like sweets. Sit with that for a second. Why It’s Misleading. OLLY isn’t uniquely bad. It’s representative — label noise stacked on doses the Spotlight already showed you don’t need, plus 17mg of chamomile (the pilot RCT used 500mg), plus a proprietary-blend premium on a £6 active ingredient. Our Verdict. ❌ Not recommended at any strength. If you genuinely need melatonin, get a USP-verified 0.3mg tablet. Costs a fiver. Works better. Won’t put a child in A&E. |
SUPERFOOD SPOTLIGHT
🥝 Kiwi Fruit
The sleep food where the RCT keeps holding up. Lin et al. (2011): two kiwis an hour before bed for four weeks cut sleep-onset latency 35%, lifted total sleep time 13%, improved PSQI 42%. A 2024 Saudi replication hit similar numbers. Mechanism is unsettled — serotonin, folate, polyphenols all candidates — but the dose is a fruit bowl. A pair of green kiwis costs about 80p. That’s the entire stack. |
DEEP DIVE
📖 Why deep sleep vanishes with age
Slow-wave sleep falls roughly 2% per decade from your 20s. By 65 the average person has lost 60–70% of it. Pase et al. (JAMA Neurology 2023) found each 1% annual drop carried a 27% higher dementia risk over the following decade. Centenarians don’t lose as much — preserved slow-wave architecture is one of the few EEG markers separating normal ageing from exceptional ageing.
The Deep Dive is the one thing I’d read this week if you read nothing else. It covers thermoregulation, auditory stimulation trials, and why zolpidem does the opposite of what you think. → Read: Deep Sleep and the Biology of Ageing · 1,400 words · 6-minute read |
BIOHACKING CORNER
🌙 The temperature-drop protocol
Core temperature has to fall about 0.5°C to initiate sleep. In older adults that drop is slower and shallower. You can shortcut it.
Hot bath 90 minutes before bed, 40–43°C, 10 minutes. Counterintuitive, but warming the periphery accelerates core cooling afterwards. A 2019 meta-analysis (n=5,322) found 9 minutes off sleep onset latency.
Bedroom 16–19°C. Most people sleep too warm. 3am wake-up hot? This is usually why.
Cool the periphery, not the room. A cooling mattress pad or bare feet outside the duvet beats air-conditioning.
Personal note. Two-week A/B on my Oura last autumn — 20°C → 17°C added 22 minutes of deep sleep per night. Nothing else changed. |
READER PULSE
📊 What you said
Last week’s poll — “Which metric matters most for tracking sleep quality?” — 47% deep sleep minutes, 31% total sleep time, 14% HRV, 8% resting heart rate. Editorial take: total sleep time is the only one with solid mortality data. Deep sleep is what you want to track and what wrist-worns estimate worst.
This week’s poll.
NEXT WEEK
🎯 Issue 09 — the peptide boom
Issue 09 turns to peptides — BPC-157, thymosin alpha-1, and the CJC-Ipamorelin stack longevity clinics charge £600 a month to prescribe. Which ones carry real human evidence? Which are rodent studies with a marketing department? Plus a Hype Check on at-home peptide kits, and a Spotlight on the one peptide with FDA approval for age-related use.
Stay curious and stay healthy!
— Christian Thomsen, Editor
Longevity Latest is published weekly by FrontWave Media Ltd. The content is for educational purposes and does not constitute medical advice. Consult your physician before starting, stopping, or changing any supplement or medication, particularly if you are pregnant, nursing, managing a chronic condition, or on prescription medication.
© 2026 FrontWave Media Ltd · Longevity Latest